Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Revenue

Medigen Biotechnology had revenue of 261.50M TWD in the quarter ending March 31, 2026, a decrease of -47.64%. This brings the company's revenue in the last twelve months to 1.34B, down -17.04% year-over-year. In the year 2025, Medigen Biotechnology had annual revenue of 1.58B with 15.28% growth.

• Revenue (ttm): 1.34B
• Revenue Growth: -17.04%
• P/S Ratio: 3.39
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.58B	209.80M	15.28%
Dec 31, 2024	1.37B	214.98M	18.57%
Dec 31, 2023	1.16B	101.77M	9.64%
Dec 31, 2022	1.06B	-2.87B	-73.08%
Dec 31, 2021	3.92B	3.31B	537.17%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error